Variations among emergency departments in the treatment of benign headache

Annals of Emergency Medicine

Volumn 41, Issue 1, 2003, Pages 90-97

  Vinson, David R ^a   Hurtado, Timothy R ^b   Vandenberg, J Toby ^c   Banwart, Leo ^c  

^a KAISER PERMANENTE   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

^c Great River Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BUTORPHANOL; CAFFEINE; DEXAMETHASONE; DIAZEPAM; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; DROPERIDOL; FENTANYL; HYDROMORPHONE; HYDROXYZINE; KETOROLAC; LORAZEPAM; METHYLPREDNISOLONE; METOCLOPRAMIDE; MORPHINE; NALBUPHINE; OPIATE; PETHIDINE; PROCHLORPERAZINE; PROMETHAZINE; SUMATRIPTAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DEMOGRAPHY; DRUG USE; EMERGENCY TREATMENT; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RESEARCH; MEDICAL SOCIETY; MIGRAINE; OUTCOMES RESEARCH; POLYPHARMACY; PRIORITY JOURNAL; UNITED STATES;

EID: 0037227042     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.24     Document Type: Article

References (27)

1. Linet MS, Stewart WF, Celentano DD, et al. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261:2211-2216.
2. Field AG, Wang E. Evaluation of the patient with nontraumatic headache: an evidence based approach. Emerg Med Clin North Am. 1999;17:127-152.
3. Vinson DR. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med. 2002;39:215-222.
4. Kelly AM. Migraine: pharmacotherapy in the emergency department. J Accid Emerg Med. 2000;17:241-245. Modified full-text available online through West J Med.: http://www.ewjm.com/cgi/content/full/173/3/189. Accessed November 15, 2002.
5. Bartleson JD. Treatment of migraine headaches. Mayo Clin Proc. 1999;74:702-708.
6. Ferrari MD. Migraine Lancet. 1998;351:1043-1051.
7. Thomas SH, Stone CK. Emergency department treatment of migraine, tension, and mixed-type headache. J Emerg Med. 1994;12:657-664.
8. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. CMAJ. 1997;156:1273-1287.
9. Matcher DB, Young WB, Rosenberg JH, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. April 2000. American Academy of Neurology US Headache Consortium. Available at: http://www.aan.com/professionals/practice/guidelines.cfm. Accessed November 15, 2002.
10. The Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
11. Miner JR, Fish SJ, Smith SW, et al. Droperidol vs. prochlorperazine for benign headaches in the emergency department. Acad Emerg Med. 2001;8:873-879.
12. Horowitz BZ, Bizovi K, Moreno R. Droperidol - behind the black box warning. Acad Emerg Med. 2002;9:615-618.
13. Wears RL. Headaches from practice guidelines. Ann Emerg Med. 2002;39:334-337.
14. Silverman ME, Shih RD. Morphine causes less nausea than meperidine when used as an analgesic in the ED [abstract]. Acad Emerg Med. 2001;8:430-431.
15. Clark RF, Wei EM, Anderson PO. Meperidine: therapeutic use and toxicity. J Emerg Med. 1995;13:797-802.
16. Talbot-Stern J, Paoloni R. Prophylactic metoclopramide is unnecessary with intravenous analgesia in the ED. Am J Emerg Med. 2000;18:653-657
17. Ernst AA, Weiss SJ, Park S, et al. Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, doubleblind clinical trial. Ann Emerg Med. 2000;36:89-94.
18. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26:541-546.
19. Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med. 1996;14:262-264.
20. Cameron JD, Lane PL, Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Acad Emerg Med. 1995;2:597-602.
21. Bell R, Montoya D, Shuaib A, et al. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med. 1990;19:1079-1082.
22. Lainez MJ, Monzon MJ. Chronic daily headache. Curr Neurol Neurosci Rep. 2001;1:118-124.
23. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol. 2000;13:277-283.
24. Lipton RB, Stewart WF, Cady R, et al. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum study. Headache. 2000;40:783-791.
25. Fiesseler FW, Kec R, Mandell M, et al. Do ED patients with migraine headache meet internationally accepted criteria? Am J Emerg Med. 2002;20:618-623.
26. Solomon S. Diagnosis of primary headache disorders. Validity of the International Headache Society criteria in clinical practice. Neurol Clin. 1997;15:15-26.
27. Solomon S, Lipton RB. Criteria for the diagnosis of migraine in clinical practice. Headache. 1991;31:384-387.